Another group found that while there were detectable T cell responses to tumor-associated antigens, responses declined with advancing disease and tumor antigen-specific CD8+ T cells were dysfunctional with low production of IFNγ, Granzyme B, and perforin [126]. This evidence concerns the gene PRF1 and neoplasm.